Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270691
Max Phase: Preclinical
Molecular Formula: C10H14N2O2
Molecular Weight: 194.23
Associated Items:
ID: ALA5270691
Max Phase: Preclinical
Molecular Formula: C10H14N2O2
Molecular Weight: 194.23
Associated Items:
Canonical SMILES: CC(C)NC(=O)c1cc(N)ccc1O
Standard InChI: InChI=1S/C10H14N2O2/c1-6(2)12-10(14)8-5-7(11)3-4-9(8)13/h3-6,13H,11H2,1-2H3,(H,12,14)
Standard InChI Key: RDXNAXNSFWHSCK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 194.23 | Molecular Weight (Monoisotopic): 194.1055 | AlogP: 1.11 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.35 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.06 | CX Basic pKa: 4.42 | CX LogP: 1.34 | CX LogD: 1.33 |
Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.49 | Np Likeness Score: -0.71 |
1. Meshram MA, Bhise UO, Makhal PN, Kaki VR.. (2021) Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR., 225 [PMID:34479036] [10.1016/j.ejmech.2021.113804] |
Source(1):